Article
DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients.
Medical oncology (Northwood, London, England) - 1 Jan 2007
Zhang Hong, Li You-ming, Zhang Hao, Jin Xi
Abstract excerpt
BACKGROUND: Dihydropyrimidine dehydrogenase (DPYD) plays an important role in the metabolism of 5-FU, which can directly influence the pharmacokinetics and toxicity of 5-FU in patients undergoing chemotherapy. However, little is known of the relationship between DPYD gene polymorphism and metabolism and chemotherapeutic toxicity of 5-FU in gastric carcinoma and colon carcinoma. The present genotyping study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.